As of 2025-05-04, the Fair Value of Acasti Pharma Inc (ACST.V) is -6.59 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.58 CAD, the upside of Acasti Pharma Inc is -1,235.93%.
With the market price of 0.58 CAD and our fair value calculation, Acasti Pharma Inc (ACST.V) is not a good investment. Investing in ACST.V stocks now will result in a potential loss of 1,235.93%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-03-31 | 2022-03-31 | 2023-03-31 | - | - | 5Y Avg | |
| Net income | -9.82 | -42.43 | - | - | -26.12 | |
| YoY growth | 50.10% | -332.11% | - | - | -141.00% | |
| Market Cap (mil) | 25.88 |
| P/E | |
| Forward P/E |
| EPS | -0.95 |
| Avg earnings growth rate | -141.00% |
| TTM earnings | -42.43 |